Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DrYo tell you that ?
Yes ...
Yes M2BIO SCIENCES INC. is currently in Pre-enrolment Patient- screening for Phase 1 Human trial in Psilocybin research for medical conditions such as alcohol addiction and related mental health diseases & cardiovascular conditions.
With University of Pletoria in Africa
Let’s go people ... time for M2Bio to shine
Psychedelic highlights | Oct. 19 – 23 https://thecannabisstock.com/2020/10/24/psychedelic-highlights-oct-19-23/
What kind of meeting ?
Always shares bloc of shares at 0.25... it’s obvious this is dilution
It’s coming guys
Wow .. almost no volume
Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds
https://www.globenewswire.com/news-release/2020/10/20/2110926/0/en/Revive-Therapeutics-Signs-Supply-Agreement-With-Havn-Life-Sciences-for-Psychedelic-Compounds.html
News out
I see nothing special ?
Dilution at 0.25 for sure since longtime ...
Have you the link of this article ?
As soon the 20 millions shares is canceled with the new ticker ... we are off the race
I’m excited to switch to MMBS ticker ...
I think we will see a reversal today
Tell us more ?
Ask go up ... good sign
The market is so hot... WUHN can pop anytime
1 billions minimum
We need to stay over 0.40 to keep the chart bullish
Michael Frank, CEO of Revive Therapeutics will be joining me on Tuesday, October 13 at 1pm to discuss Bucillamine as a potential treatment for #COVID19. Currently Bucillamine is in FDA Phase 3 clinical trials.
Thanks!! Can't wait!
— Sheltie Dad (@sheltie_dad) October 6, 2020
I talk with him and he say the NAC study was not the right target ... might be better to target the glutathione pathway.
You’re wrong ... Dr Boulware thinks that Buccilamine is interesting and worth studying..,
A new Chief Operating Officer for M2Bio Science inc | WUHN https://thecannabisstock.com/2020/10/05/a-new-chief-operating-officer-for-m2bio-science-inc-wuhn/
Listen at 1.00 ... Trump mention other therapeutics coming out soon...
— Donald J. Trump (@realDonaldTrump) October 3, 2020
Close green ... go go
Bid increase .. go slap the ask ... the chart is bullish
Greenn
L2 someone
I feel a huge news tomorrow ...
L2 going up fast ... 0.50+ today
Boum ... going up
Tell us more
Revive Therapeutics finalizes five clinical sites for their FDA COVID-19 Phase 3 https://thecannabisstock.com/2020/09/29/revive-therapeutics-finalizes-five-clinical-sites-for-their-fda-covid-19-phase-3/
Article: Investors: If you like Compass Pathways you will love M2Bio Sciences. https://thecannabisstock.com/2020/09/28/investors-if-you-like-compass-pathways-you-will-love-m2bio-sciences/
Great time for a juicy news
Some dumping today ...